Bayesian Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-7,638
| Closed | -$213K | – | 739 |
|
2023
Q3 | $213K | Buy |
+7,638
| New | +$213K | 0.02% | 538 |
|
2022
Q4 | – | Sell |
-15,378
| Closed | -$505K | – | 773 |
|
2022
Q3 | $505K | Sell |
15,378
-600
| -4% | -$19.7K | 0.1% | 282 |
|
2022
Q2 | $503K | Buy |
+15,978
| New | +$503K | 0.09% | 335 |
|
2022
Q1 | – | Sell |
-8,300
| Closed | -$508K | – | 769 |
|
2021
Q4 | $508K | Sell |
8,300
-400
| -5% | -$24.5K | 0.16% | 169 |
|
2021
Q3 | $650K | Buy |
+8,700
| New | +$650K | 0.19% | 144 |
|